These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25010102)

  • 1. Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation.
    Slocum C; Coats SR; Hua N; Kramer C; Papadopoulos G; Weinberg EO; Gudino CV; Hamilton JA; Darveau RP; Genco CA
    PLoS Pathog; 2014 Jul; 10(7):e1004215. PubMed ID: 25010102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection with a common oral pathogen.
    Hayashi C; Papadopoulos G; Gudino CV; Weinberg EO; Barth KR; Madrigal AG; Chen Y; Ning H; LaValley M; Gibson FC; Hamilton JA; Genco CA
    J Immunol; 2012 Oct; 189(7):3681-8. PubMed ID: 22956579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses.
    Hayashi C; Madrigal AG; Liu X; Ukai T; Goswami S; Gudino CV; Gibson FC; Genco CA
    J Innate Immun; 2010; 2(4):334-43. PubMed ID: 20505314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porphyromonas gingivalis mediated periodontal disease and atherosclerosis: disparate diseases with commonalities in pathogenesis through TLRs.
    Gibson FC; Genco CA
    Curr Pharm Des; 2007; 13(36):3665-75. PubMed ID: 18220804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-dependent inflammatory oral bone loss.
    Papadopoulos G; Weinberg EO; Massari P; Gibson FC; Wetzler LM; Morgan EF; Genco CA
    J Immunol; 2013 Feb; 190(3):1148-57. PubMed ID: 23264656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of PGN_1123 as the Gene Encoding Lipid A Deacylase, an Enzyme Required for Toll-Like Receptor 4 Evasion, in Porphyromonas gingivalis.
    Jain S; Chang AM; Singh M; McLean JS; Coats SR; Kramer RW; Darveau RP
    J Bacteriol; 2019 Jun; 201(11):. PubMed ID: 30782639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice.
    Hayashi C; Viereck J; Hua N; Phinikaridou A; Madrigal AG; Gibson FC; Hamilton JA; Genco CA
    Atherosclerosis; 2011 Mar; 215(1):52-9. PubMed ID: 21251656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Porphyromonas gingivalis cell invasion required for atherogenesis? Pharmacotherapeutic implications.
    Amar S; Wu SC; Madan M
    J Immunol; 2009 Feb; 182(3):1584-92. PubMed ID: 19155507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways.
    Hayashi C; Gudino CV; Gibson FC; Genco CA
    Mol Oral Microbiol; 2010 Oct; 25(5):305-16. PubMed ID: 20883220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver X receptors contribute to periodontal pathogen-elicited inflammation and oral bone loss.
    Huang N; Shaik-Dasthagirisaheb YB; LaValley MP; Gibson FC
    Mol Oral Microbiol; 2015 Dec; 30(6):438-50. PubMed ID: 25946408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogen-accelerated atherosclerosis occurs early after exposure and can be prevented via immunization.
    Miyamoto T; Yumoto H; Takahashi Y; Davey M; Gibson FC; Genco CA
    Infect Immun; 2006 Feb; 74(2):1376-80. PubMed ID: 16428788
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Makkawi H; Hoch S; Burns E; Hosur K; Hajishengallis G; Kirschning CJ; Nussbaum G
    Front Cell Infect Microbiol; 2017; 7():359. PubMed ID: 28848717
    [No Abstract]   [Full Text] [Related]  

  • 13. Porphyromonas gingivalis fimbriae dampen P2X7-dependent interleukin-1β secretion.
    Morandini AC; Ramos-Junior ES; Potempa J; Nguyen KA; Oliveira AC; Bellio M; Ojcius DM; Scharfstein J; Coutinho-Silva R
    J Innate Immun; 2014; 6(6):831-45. PubMed ID: 24925032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of TLR2 in early innate immune response to acute pulmonary infection with Porphyromonas gingivalis in mice.
    Hajishengallis G; Wang M; Bagby GJ; Nelson S
    J Immunol; 2008 Sep; 181(6):4141-9. PubMed ID: 18768871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetra- and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-κB signal transduction cascade and immuno-inflammatory response in human gingival fibroblasts.
    Herath TD; Darveau RP; Seneviratne CJ; Wang CY; Wang Y; Jin L
    PLoS One; 2013; 8(3):e58496. PubMed ID: 23554896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyromonas gingivalis Infection Accelerates Atherosclerosis Mediated by Oxidative Stress and Inflammatory Responses in ApoE-/- Mice.
    Xuan Y; Shi Q; Liu GJ; Luan QX; Cai Y
    Clin Lab; 2017 Oct; 63(10):1627-1637. PubMed ID: 29035447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone impedes Porphyromonas gingivalis-accelerated atherosclerosis by downregulating the TLR/NF-κB signaling pathway in atherosclerotic mice.
    Pan S; Lei L; Chen S; Li H; Yan F
    Int Immunopharmacol; 2014 Dec; 23(2):701-8. PubMed ID: 25445963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperlipidemia impaired innate immune response to periodontal pathogen porphyromonas gingivalis in apolipoprotein E knockout mice.
    Lei L; Li H; Yan F; Xiao Y
    PLoS One; 2013; 8(8):e71849. PubMed ID: 23977160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porphyromonas gingivalis selectively up-regulates the HIV-1 coreceptor CCR5 in oral keratinocytes.
    Giacaman RA; Nobbs AH; Ross KF; Herzberg MC
    J Immunol; 2007 Aug; 179(4):2542-50. PubMed ID: 17675516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingolipid-Containing Outer Membrane Vesicles Serve as a Delivery Vehicle To Limit Macrophage Immune Response to Porphyromonas gingivalis.
    Rocha FG; Ottenberg G; Eure ZG; Davey ME; Gibson FC
    Infect Immun; 2021 Mar; 89(4):. PubMed ID: 33361202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.